Analyst Ratings for Aslan Pharma (ASLN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/31/2023 | Roth/MKM | Dylan Dupuls | New Coverage | Buy (N/A) |
15.00 (N/A) |
3.91 (0.60) |
-84.65% | Details |
| 7/9/2021 | Jefferies | Maury Raycroft | New Coverage | Buy (N/A) |
N/A (N/A) |
3.16 (0.60) |
-81.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
